723 related articles for article (PubMed ID: 3934894)
1. Hyperthyroidism caused by a pituitary thyrotrophin-secreting tumour with excessive secretion of thyrotrophin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman.
Kamoi K; Mitsuma T; Sato H; Yokoyama M; Washiyama K; Tanaka R; Arai O; Takasu N; Yamada T
Acta Endocrinol (Copenh); 1985 Nov; 110(3):373-82. PubMed ID: 3934894
[TBL] [Abstract][Full Text] [Related]
2. Hyperthyroidism due to inappropriate TSH secretion with associated hyperprolactinaemia--a case report and review of the literature.
Spitz IM; Sheinfeld M; Glasser B; Hirsch HJ
Postgrad Med J; 1984 May; 60(703):328-35. PubMed ID: 6429655
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with bromocriptine of a plurihormonal pituitary adenoma secreting thyrotropin, growth hormone and prolactin.
Shimatsu A; Murabe H; Nakamura Y; Mizuta H; Ihara C; Nakao K
Endocr J; 1999 Feb; 46(1):159-65. PubMed ID: 10426581
[TBL] [Abstract][Full Text] [Related]
4. Hyperthyroidism and acromegaly caused by a pituitary TSH- and GH-secreting tumour.
Lamberg BA; Pelkonen R; Gordin A; Haltia M; Wahlström T; Paetau A; Leppäluoto J
Acta Endocrinol (Copenh); 1983 May; 103(1):7-14. PubMed ID: 6305077
[TBL] [Abstract][Full Text] [Related]
5. Thyrotropin-releasing hormone (TRH) binding sites and thyrotropin response to TRH are regulated by thyroid hormones in human thyrotropic adenomas.
Le Dafniet M; Brandi AM; Kujas M; Chanson P; Peillon F
Eur J Endocrinol; 1994 Jun; 130(6):559-64. PubMed ID: 8205254
[TBL] [Abstract][Full Text] [Related]
6. Induction of hypothyroidism and hypoprolactinemia by growth hormone producing rat pituitary tumors.
Seo H; Refetoff S; Fang VS
Endocrinology; 1977 Jan; 100(1):216-26. PubMed ID: 401484
[TBL] [Abstract][Full Text] [Related]
7. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
9. The thyrotrophin response to thyrotrophin releasing hormone during treatment in patients with Graves' disease.
Haug E; Frey HM; Sand T
Acta Endocrinol (Copenh); 1977 Jun; 85(2):335-44. PubMed ID: 405834
[TBL] [Abstract][Full Text] [Related]
10. A human pituitary adenoma secreting thyrotropin and prolactin: immunohistochemical, biochemical, and cell culture studies.
Jaquet P; Hassoun J; Delori P; Gunz G; Grisoli F; Weintraub BD
J Clin Endocrinol Metab; 1984 Nov; 59(5):817-24. PubMed ID: 6480809
[TBL] [Abstract][Full Text] [Related]
11. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
Van den Berghe G; de Zegher F; Bowers CY; Wouters P; Muller P; Soetens F; Vlasselaers D; Schetz M; Verwaest C; Lauwers P; Bouillon R
Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
[TBL] [Abstract][Full Text] [Related]
12. Thyrotropin-secreting pituitary adenomas: report of seven cases.
Beckers A; Abs R; Mahler C; Vandalem JL; Pirens G; Hennen G; Stevenaert A
J Clin Endocrinol Metab; 1991 Feb; 72(2):477-83. PubMed ID: 1704011
[TBL] [Abstract][Full Text] [Related]
13. Hyperthyroidism due to a pituitary TSH secreting tumour with amenorrhoea-galactorrhoea.
Benoit R; Pearson-Murphy BE; Robert F; Marcovitz S; Hardy J; Tsoukas G; Gardiner RJ
Clin Endocrinol (Oxf); 1980 Jan; 12(1):11-9. PubMed ID: 7189698
[TBL] [Abstract][Full Text] [Related]
14. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
Sato A; Yamada T; Aizawa T; Ichikawa K; Komiya I; Takasu N; Takemura Y
J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
[TBL] [Abstract][Full Text] [Related]
15. Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting alpha-subunit alone and another cosecreting alpha-subunit and thyrotropin.
Terzolo M; Orlandi F; Bassetti M; Medri G; Paccotti D; Cortelazzi D; Angeli A; Beck-Peccoz P
J Clin Endocrinol Metab; 1991 Feb; 72(2):415-21. PubMed ID: 1704010
[TBL] [Abstract][Full Text] [Related]
16. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
17. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin-secreting pituitary adenoma: a case report.
Nagai K; Sakata S; Wu CC; Wada H; Yokoyama K; Takada M; Kashiwai T; Tokimitsu N
Endocrinol Jpn; 1992 Aug; 39(4):413-9. PubMed ID: 1446657
[TBL] [Abstract][Full Text] [Related]
19. A functional thyrotropin- and growth hormone-secreting pituitary adenoma with a ultrastructurally monomorphic feature: a case study.
Ozawa Y; Kameya T; Kasuga A; Naritaka H; Kanda N; Maruyama H; Saruta T
Endocr J; 1998 Apr; 45(2):211-9. PubMed ID: 9700474
[TBL] [Abstract][Full Text] [Related]
20. Thyrotoxicosis and a thyrotropin-secreting pituitary tumor causing unilateral exophthalmos.
Yovos JG; Falko JM; O'Dorisio TM; Malarkey WB; Cataland S; Capen CC
J Clin Endocrinol Metab; 1981 Aug; 53(2):338-43. PubMed ID: 6788793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
